These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33167948)

  • 1. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials.
    Ayati Z; Yang G; Ayati MH; Emami SA; Chang D
    BMC Complement Med Ther; 2020 Nov; 20(1):333. PubMed ID: 33167948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs.
    Avgerinos KI; Vrysis C; Chaitidis N; Kolotsiou K; Myserlis PG; Kapogiannis D
    Neurol Sci; 2020 Oct; 41(10):2747-2754. PubMed ID: 32445136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.
    Akhondzadeh S; Sabet MS; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SSh; Yousefi MH; Alimardani R; Jamshidi A; Zare F; Moradi A
    J Clin Pharm Ther; 2010 Oct; 35(5):581-8. PubMed ID: 20831681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.
    Hausenblas HA; Heekin K; Mutchie HL; Anton S
    J Integr Med; 2015 Jul; 13(4):231-40. PubMed ID: 26165367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis.
    Dai L; Chen L; Wang W
    J Nerv Ment Dis; 2020 Apr; 208(4):269-276. PubMed ID: 32221179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
    Hausenblas HA; Saha D; Dubyak PJ; Anton SD
    J Integr Med; 2013 Nov; 11(6):377-83. PubMed ID: 24299602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese Herbal Medicine for Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes.
    Dong L; May BH; Feng M; Hyde AJ; Tan HY; Guo X; Zhang AL; Lu C; Xue CC
    Phytother Res; 2016 Oct; 30(10):1592-1604. PubMed ID: 27416935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study.
    Lu C; Ke L; Li J; Zhao H; Lu T; Mentis AFA; Wang Y; Wang Z; Polissiou MG; Tang L; Tang H; Yang K
    Phytomedicine; 2021 Oct; 91():153699. PubMed ID: 34419735
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    D'Onofrio G; Nabavi SM; Sancarlo D; Greco A; Pieretti S
    Curr Neuropharmacol; 2021; 19(9):1606-1616. PubMed ID: 33441068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.